91 – 100 of 151
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Autologous plasma for the study of anaphylatoxinkinetics in man
(2009) XXII Congress of the International Society of Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 7(s2).
- Contribution to journal › Published meeting abstract
-
Mark
Prothrombin complex concentrate and effects on thecone and plate analyser
(2009) XXII Congress of the International Society of Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 7(s2). p.885-885
- Contribution to journal › Published meeting abstract
-
Mark
Comparison of two different heparin doses inperipheral vascular surgery
(2009) XXII Congress of the International Society of Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 7(s2).
- Contribution to journal › Published meeting abstract
-
Mark
Comparison of two infusionrates of antithrombinconcentrate in cardiopulmonary bypass surgery
(2009) XXII Congress of the International Society of Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 7(s2). p.1075-1075
- Contribution to journal › Published meeting abstract
-
Mark
Bedside point of care coagulation testing forindividualized antivitamin K reversal in emergencysurgery
(2009) XXII Congress of the International Society of Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 7(s2). p.1167-1167
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)
- Contribution to journal › Article
-
Mark
Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats
- Contribution to journal › Article
- 2007
-
Mark
An immunochemical method for quantitative determination of latent antithrombin, the reactive center loop-inserted uncleaved form of antithrombin.
- Contribution to journal › Article
-
Mark
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)
- Contribution to journal › Article
-
Mark
Von Willebrand factor/factor VIII concentrate (Haemate(R) P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery.
- Contribution to journal › Article
